Progressive Supranuclear Palsy Psp clinical trials

Explore recruiting progressive supranuclear palsy psp clinical trials.

Recruiting progressive supranuclear palsy psp studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Progressive Supranuclear Palsy Psp trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 2b/3 Study of Safety and Efficacy of AMX0035 in Progressive Supranuclear Palsy (ORION)

Bulgaria, Austria, Netherlands, Sweden, Belgium, Spain +4 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

An Open-Label Extension Study to Evaluate the Safety and Tolerability of Long-Term UCB0107 Administration in Study Participants With Progressive Supranuclear Palsy

Spain, Germany, Belgium

Human Pharmacology (Phase I)- Other EU CTIS Study details

A randomized, double-blind, placebo-controlled, Phase 2 study to assess the efficacy, safety, and pharmacokinetics of FNP-223 (oral formulation) to slow the disease progression of progressive supranuclear palsy (PSP) PROSPER

Italy, France, Poland, Germany, Portugal, Spain +1 more

Therapeutic exploratory (Phase II) EU CTIS Study details

Longitudinal study with positron emission tomography using [18F]PI-2620 in primary tauopathies. Proof-of-concept study

Spain

Phase I and Phase II (Integrated)- Other EU CTIS Study details

PsyPal; Psilocybin Therapy for Psychological Distress in Palliative Patients

Portugal, Czechia, Netherlands, Denmark

Therapeutic exploratory (Phase II) EU CTIS Study details

Progressive Supranuclear Palsy Psp trials by city

Progressive Supranuclear Palsy Psp in Toronto Progressive Supranuclear Palsy Psp in Vancouver Progressive Supranuclear Palsy Psp in Montreal Progressive Supranuclear Palsy Psp in Calgary Progressive Supranuclear Palsy Psp in Edmonton Progressive Supranuclear Palsy Psp in Ottawa Progressive Supranuclear Palsy Psp in Winnipeg Progressive Supranuclear Palsy Psp in Quebec City Progressive Supranuclear Palsy Psp in Hamilton Progressive Supranuclear Palsy Psp in Kitchener Progressive Supranuclear Palsy Psp in London Progressive Supranuclear Palsy Psp in Halifax Progressive Supranuclear Palsy Psp in New York Progressive Supranuclear Palsy Psp in Los Angeles Progressive Supranuclear Palsy Psp in Chicago Progressive Supranuclear Palsy Psp in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease